Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 3
- Medical Cannabis
Majority of UK Medical Cannabis Flower Now at 25% THC or Above, New Data Shows
Earlier this month, we published new data from two separate Freedom of Information (FOI) requests providing the most complete and up-to-date picture yet of the UK’s medical cannabis market.
- Interviews
Remexian Surging Ahead One Year On From High Tide Purchase
Whilst expressing empathy with patients impacted by the recent German crackdown on cannabis flower, the head of the country’s leading wholesaler is bullish about its prospects – with orders up 50% since its purchase by Canadian cannabis giant High Tide.
- Cultivation
The Science of the Cannabis Post-Harvest Process
James Duckenfield, CEO of Glass Pharms®, explains the company’s post-harvest process, including drying and curing, and why freeze-drying is never part of it.
- Cultivation
Canopy Focuses On Fundamentals Ditching ‘Financial Instrument’ Era
CANOPY Growth is primed to cull a host of existing brands as it looks to build a multi-market, seed-to-patient model and distance itself from a ‘false starts’ legacy, says CEO Luc Mongeau.
- M&A Activity
Aurora Buys UK Pharmacy and Import Licence for £2.1m, Securing ‘Direct Route’ to Patients
As Aurora faces down an unsolicited takeover bid from one of the world’s largest cannabis companies, it has continued to expand its reach in what it sees as the markets of the near future.
- Patient Access
Germany’s Medical Cannabis Insurance Reform Descends Into Chaos as Regulators Turn on Each Other
Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV).
- Interviews
Ireland’s Dunbar Pharma Launches First Plant-Derived Dronabinol in UK Through IPS Pharma
Irish pharmaceutical cannabis manufacturer Dunbar Pharmaceuticals has today launched the first plant-derived dronabinol active ingredient into the UK market.
- Medical Cannabis
UK Medical Cannabis Prescriptions Hit 1.7 Million in 2025 as ACMD Review Approaches
More than a year has passed since the Advisory Council on the Misuse of Drugs (ACMD) was commissioned to conduct a formal review of the UK’s medical cannabis industry.
- International Regulation
Isreal Reopens Canadian Cannabis Dumping Case, This Time With a Route Around Its Finance Minister
Israel’s Ministry of Economy and Industry has already reopened its anti-dumping investigation into Canadian medical cannabis, just a week after a procedural defect forced the same case to close.
- M&A Activity
Argent Biopharma’s CannEpil to Target $3bn Veterinary Pain Market, Weeks After Debt-Relief Deal
Argent Biopharma’s (RGT) flagship CannEpil cannabis drug is set to pivot into the veterinary market, just weeks after it signed away the commercial rights in exchange for debt relief.
- Clinical Research
The science of THCV
Cannabis research has historically concentrated on THC and CBD, and for good reason.
- Adult-Use
Thailand Presses Medical-Only Cannabis Bill Toward Cabinet as Enforcement Drive Widens
Thailand’s Ministry of Public Health is pressing ahead with a draft Cannabis and Hemp Act that would restrict its liberal cannabis market to purely medical and research use cases.
